199 related articles for article (PubMed ID: 25893008)
1. Management of Cancer-related Cognitive Dysfunction-Conceptualization Challenges and Implications for Clinical Research and Practice.
Jean-Pierre P
US Oncol; 2010; 6():9-12. PubMed ID: 25893008
[TBL] [Abstract][Full Text] [Related]
2. Coping with cancer-related cognitive dysfunction: a scoping review of the literature.
Sleight A
Disabil Rehabil; 2016; 38(4):400-8. PubMed ID: 25885669
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Related Cognitive Dysfunction: A Narrative Review for Clinical Practice.
Rick O; Gerhardt A; Schilling G
Oncol Res Treat; 2024; 47(5):218-223. PubMed ID: 38471462
[TBL] [Abstract][Full Text] [Related]
4. The Development and Evaluation of a Patient Educational Resource for Cancer-Related Cognitive Dysfunction.
Abraham EH; Khan B; Ling E; Bernstein LJ
J Cancer Educ; 2022 Feb; 37(1):111-119. PubMed ID: 32557399
[TBL] [Abstract][Full Text] [Related]
5. A brief psychoeducational intervention improves memory contentment in breast cancer survivors with cognitive concerns: results of a single-arm prospective study.
Bernstein LJ; McCreath GA; Nyhof-Young J; Dissanayake D; Rich JB
Support Care Cancer; 2018 Aug; 26(8):2851-2859. PubMed ID: 29525841
[TBL] [Abstract][Full Text] [Related]
6. Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study.
McDeed AP; Van Dyk K; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Nakamura ZM; Rentscher KE; Saykin AJ; Small BJ; Root JC; Jim H; Patel SK; Mcdonald BC; Mandelblatt JS; Ahn J
JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38556480
[TBL] [Abstract][Full Text] [Related]
7. Cognitive behavioral therapy for cancer-related cognitive dysfunction.
Kucherer S; Ferguson RJ
Curr Opin Support Palliat Care; 2017 Mar; 11(1):46-51. PubMed ID: 27898511
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction.
Ferguson RJ; Sigmon ST; Pritchard AJ; LaBrie SL; Goetze RE; Fink CM; Garrett AM
Cancer; 2016 Jun; 122(11):1782-91. PubMed ID: 27135464
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development.
Jean-Pierre P; Johnson-Greene D; Burish TG
Support Care Cancer; 2014 Aug; 22(8):2251-60. PubMed ID: 24671433
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-related cognitive dysfunction and effects on quality of life in gynecologic cancer patients.
Pearre DC; Bota DA
Expert Rev Qual Life Cancer Care; 2018; 3(1):19-26. PubMed ID: 30775449
[TBL] [Abstract][Full Text] [Related]
11. Remote, Computerised Cognitive Assessment for Breast Cancer- and Treatment-Related Cognitive Dysfunction: Psychometric Characteristics of the Cogsuite Neurocognitive Battery.
Root JC; Gaynor AM; Ahsan A; Jung D; Schofield E; Ryan E; Li Y; Ahles TA
Arch Clin Neuropsychol; 2023 Jul; 38(5):699-713. PubMed ID: 36655820
[TBL] [Abstract][Full Text] [Related]
12. Neuroepidemiology of cancer and treatment-related neurocognitive dysfunction in adult-onset cancer patients and survivors.
Jean-Pierre P; McDonald BC
Handb Clin Neurol; 2016; 138():297-309. PubMed ID: 27637965
[TBL] [Abstract][Full Text] [Related]
13. Research advances on how metformin improves memory impairment in "chemobrain".
Alhowail A; Chigurupati S
Neural Regen Res; 2022 Jan; 17(1):15-19. PubMed ID: 34100420
[TBL] [Abstract][Full Text] [Related]
14. Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment.
Binarelli G; Duivon M; Joly F; Ahmed-Lecheheb D; Lange M
Expert Rev Neurother; 2023 Mar; 23(3):249-268. PubMed ID: 36951414
[TBL] [Abstract][Full Text] [Related]
15. Cognitive rehabilitation for cancer-related cognitive dysfunction: a systematic review.
Fernandes HA; Richard NM; Edelstein K
Support Care Cancer; 2019 Sep; 27(9):3253-3279. PubMed ID: 31147780
[TBL] [Abstract][Full Text] [Related]
16. [Chemobrain - cognitive disorders after chemotherapy].
Kupryjaniuk A; Sobstyl M
Pol Merkur Lekarski; 2022 Dec; 50(300):398-400. PubMed ID: 36645690
[TBL] [Abstract][Full Text] [Related]
17. Cognitive dysfunction in cancer patients: an educational needs area improved by a single intervention.
Vetto IP; Vetto JT
J Cancer Educ; 2007; 22(3):197-201. PubMed ID: 17760529
[TBL] [Abstract][Full Text] [Related]
18. Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications.
Selamat MH; Loh SY; Mackenzie L; Vardy J
PLoS One; 2014; 9(9):e108002. PubMed ID: 25259847
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of psychosocial interventions for cognitive dysfunction in cancer patients who have received chemotherapy: a systematic review.
Hines S; Ramis MA; Pike S; Chang AM
Worldviews Evid Based Nurs; 2014 Jun; 11(3):187-93. PubMed ID: 24842532
[TBL] [Abstract][Full Text] [Related]
20. [Chemobrain].
Szentmartoni G; Makkos Z; Dank M
Neuropsychopharmacol Hung; 2018 Sep; 20(3):112-116. PubMed ID: 30459288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
